Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1

The monarchE Cohort 1 patient population was enrolled based on high-risk clinicopathological features that can easily be identified as part of routine clinical breast cancer evaluation. Efficacy data from Cohort 1 demonstrate substantial evidence of benefit for adjuvant abemaciclib+ET in patients wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2023-01, Vol.28 (1), p.e77-e81
Hauptverfasser:	Toi, Masakazu, Boyle, Frances, Im, Young-Hyuck, Reinisch, Mattea, Molthrop, David, Jiang, Zefei, Wei, Ran, Sapunar, Francisco, Grimes, Brenda R, Nabinger, Sarah Cassidy, Johnston, Stephen R D
Format:	Artikel
Sprache:	eng
Schlagworte:	Aminopyridines - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Benzimidazoles - therapeutic use Breast cancer Breast Neoplasms - pathology Care and treatment Complications and side effects Diagnosis Female Health aspects Hormone therapy Humans Medical colleges Patient outcomes Pharmaceutical industry Protein Kinase Inhibitors - therapeutic use Receptor, ErbB-2 - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!